Acurx Pharmaceuticals, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACXP, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
5
Funds holding
$15724
Total value held
Buying
2 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $11625 | 7500 | +1000 | +15.38% |
| 2 | Wells Fargo & Company/Mn | $3565 | 2300 | — | Held |
| 3 | Barclays Plc | $436 | 281 | -99 | -26.05% |
| 4 | Blackrock, Inc. | $93 | 60 | — | Held |
| 5 | Ubs Group Ag | $5 | 3 | +3 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.